Matthews, Gail

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Journal Article

van Santen, Daniela K; Stewart, Ashleigh; Doyle, Joseph S; Stoové, Mark A; Asselin, Jason; Klein, Marina B; Young, Jim; Berenguer, Juan; Jarrin, Inmaculada; Lacombe, Karine; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Rauch, Andri; Mugglin, Catrina; Matthews, Gail; Prins, Maria; Smit, Colette; Boyd, Anders; ... (2024). Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International journal of epidemiology, 53(1) Oxford University Press 10.1093/ije/dyad154

Koopsen, Jelle; Matthews, Gail; Rockstroh, Juergen; Applegate, Tanya L; Bhagani, Sanjay; Rauch, Andri; Grebely, Jason; Sacks-Davis, Rachel; Ingiliz, Patrick; Boesecke, Christoph; Rebers, Sjoerd; Feld, Jordan; Bruneau, Julie; Martinello, Marianne; Hellard, Margaret; Dore, Gregory J; Schinkel, Janke; van der Valk, Marc (2023). Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis. The Lancet Microbe, 4(8), e622-e631. Elsevier 10.1016/S2666-5247(23)00108-8

Lundgren, Jens D; Babiker, Abdel G; Sharma, Shweta; Grund, Birgit; Phillips, Andrew N; Matthews, Gail; Kan, Virginia L; Aagaard, Bitten; Abo, Inka; Alston, Beverly; Arenas-Pinto, Alejandro; Avihingsanon, Anchalee; Badal-Faesen, Sharlaa; Brites, Carlos; Carey, Cate; Casseb, Jorge; Clarke, Amanda; Collins, Simon; Corbelli, Giulio Maria; Dao, Sounkalo; ... (2023). Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evidence, 2(3) NEJM Group 10.1056/evidoa2200302

van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810

Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056

This list was generated on Thu Apr 25 08:30:40 2024 CEST.
Provide Feedback